[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Generic Drugs Market: Market Size, Forecast, Insights, and Competitive Landscape

November 2022 | 129 pages | ID: U972511B12A2EN
Prodture

US$ 2,299.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The United States generic drugs market is expected to grow at a CAGR of around 9.8% during 2023-2030. This report on United States generic drugs market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the United States generic drugs market by segmenting the market based on type, therapy area, drug delivery, and distribution channel. Also, detailed profiles of companies operating in the United States generic drugs market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers
  • Increasing Prevalence of Chronic Diseases
  • Growth in Geriatric Population
  • Increasing Investments in Advertising
Market Challenges
  • Stringent Governmental Regulations
  • Adverse Effects Associated With Drugs
Historical & Forecast Period

Base Year: 2022

Historical Period: 2018-2022

Forecast Period: 2023-2030

Market by Type
  • Unbranded
  • Branded
Market by Therapy Area
  • CNS
  • Cardiovascular
  • Dermatology
  • Genitourinary/Hormonal
  • Respiratory
  • Rheumatology
  • Diabetes
  • Oncology
  • Others
Market by Drug Delivery
  • Oral
  • Injectable
  • Dermal/Topical
  • Inhalers
Market by Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
1. PREFACE

1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
  1.4.1 Phase I
  1.4.2 Phase II
  1.4.3 Phase III
1.5 Assumptions

2. KEY INSIGHTS

3. UNITED STATES GENERIC DRUGS MARKET

3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges

4. UNITED STATES GENERIC DRUGS MARKET ANALYSIS

4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19

5. UNITED STATES GENERIC DRUGS MARKET BY TYPE

5.1. Introduction
5.2 Unbranded
5.3 Branded

6. UNITED STATES GENERIC DRUGS MARKET BY THERAPY AREA

6.1 Introduction
6.2 CNS
6.3 Cardiovascular
6.4 Dermatology
6.5 Genitourinary/Hormonal
6.6 Respiratory
6.7 Rheumatology
6.8 Diabetes
6.9 Oncology
6.10 Others

7. UNITED STATES GENERIC DRUGS MARKET BY DRUG DELIVERY

7.1 Introduction
7.2 Oral
7.3 Injectable
7.4 Dermal/Topical
7.5 Inhalers

8. UNITED STATES GENERIC DRUGS MARKET BY DISTRIBUTION CHANNEL

8.1 Introduction
8.2 Hospital Pharmacies
8.3 Retail Pharmacies

9. SWOT ANALYSIS

10. PORTER’S FIVE FORCES

11. MARKET VALUE CHAIN ANALYSIS

12. COMPETITIVE LANDSCAPE

12.1 Competitive Scenario
12.2 Company Profiles
  12.2.1 Teva
  12.2.2 Mylan
  12.2.3 Actavis (Teva)
  12.2.4 Sandoz (Novartis)
  12.2.5 Sun Pharma
  12.2.6 Par Pharmaceuticals (Endo Pharmaceuticals)
  12.2.7 Lupin Pharmaceuticals
  12.2.8 Dr Reddy’s
  12.2.9 Hospira (Pfizer)
  12.2.10 Baxter International Inc
  12.2.11 GlaxoSmithKline Plc.
  12.2.12 Eli Lilly and Company
  12.2.13 ALLERGAN
  12.2.14 STADA Arzneimittel AG
  12.2.15 Abbott Laboratories


LIST OF TABLES

Table 1: United States Generic Drugs Market Portraiture
Table 2: United States Generic Drugs Market by Type (in US$ Million), 2022 & 2030
Table 3: United States Generic Drugs Market by Therapy Area (in US $ Million), 2022 & 2030
Table 4: United States Generic Drugs Market by Drug Delivery (in US $ Million), 2022 & 2030
Table 5: United States Generic Drugs Market by Distribution Channel (in US$ Million), 2022 & 2030
Table 6: List of Key Players

LIST OF FIGURES

Figure 1: United States Generic Drugs Market (in US$ Million), 2018-2022
Figure 2: United States Generic Drugs Market by Type, 2022
Figure 3: United States Generic Drugs Market by Therapy Area, 2022
Figure 4: United States Generic Drugs Market by Drug Delivery, 2022
Figure 5: United States Generic Drugs Market by Distribution Channel, 2022
Figure 6: United States Generic Drugs Market (in US$ Million), 2023-2030
Figure 7: United States Generic Drugs Market by Type (in %), 2022 & 2030
Figure 8: United States Unbranded Generic Drugs Market (in US$ Million), 2018-2022
Figure 9: United States Unbranded Generic Drugs Market (in US$ Million), 2023-2030
Figure 10: United States Branded Generic Drugs Market (in US$ Million), 2018-2022
Figure 11: United States Branded Generic Drugs Market (in US$ Million), 2023-2030
Figure 12: United States Generic Drugs Market by Therapy Area (in %), 2022 & 2030
Figure 13: United States CNS Generic Drugs Market (in US$ Million), 2018-2022
Figure 14: United States CNS Generic Drugs Market (in US$ Million), 2023-2030
Figure 15: United States Cardiovascular Generic Drugs Market (in US$ Million), 2018-2022
Figure 16: United States Cardiovascular Generic Drugs Market (in US$ Million), 2023-2030
Figure 17: United States Dermatology Generic Drugs Market (in US$ Million), 2018-2022
Figure 18: United States Dermatology Generic Drugs Market (in US$ Million), 2023-2030
Figure 19: United States Genitourinary/Hormonal Generic Drugs Market (in US$ Million), 2018-2022
Figure 20: United States Genitourinary/Hormonal Generic Drugs Market (in US$ Million), 2023-2030
Figure 21: United States Respiratory Generic Drugs Market (in US$ Million), 2018-2022
Figure 22: United States Respiratory Generic Drugs Market (in US$ Million), 2023-2030
Figure 23: United States Rheumatology Generic Drugs Market (in US$ Million), 2018-2022
Figure 24: United States Rheumatology Generic Drugs Market (in US$ Million), 2023-2030
Figure 25: United States Diabetes Generic Drugs Market (in US$ Million), 2018-2022
Figure 26: United States Diabetes Generic Drugs Market (in US$ Million), 2023-2030
Figure 27: United States Oncology Generic Drugs Market (in US$ Million), 2018-2022
Figure 28: United States Oncology Generic Drugs Market (in US$ Million), 2023-2030
Figure 29: United States Others Generic Drugs Market (in US$ Million), 2018-2022
Figure 30: United States Others Generic Drugs Market (in US$ Million), 2023-2030
Figure 31: United States Generic Drugs Market by Drug Delivery (in %), 2022 & 2030
Figure 32: United States Oral Generic Drugs Market (in US$ Million), 2018-2022
Figure 33: United States Oral Generic Drugs Market (in US$ Million), 2023-2030
Figure 34: United States Injectable Generic Drugs Market (in US$ Million), 2018-2022
Figure 35: United States Injectable Generic Drugs Market (in US$ Million), 2023-2030
Figure 36: United States Dermal/Topical Generic Drugs Market (in US$ Million), 2018-2022
Figure 37: United States Dermal/Topical Generic Drugs Market (in US$ Million), 2023-2030
Figure 38: United States Inhalers Generic Drugs Market (in US$ Million), 2018-2022
Figure 39: United States Inhalers Generic Drugs Market (in US$ Million), 2023-2030
Figure 40: United States Generic Drugs Market by Distribution Channel (in %), 2022 & 2030
Figure 41: United States Hospital Pharmacies Generic Drugs Market (in US$ Million), 2018-2022
Figure 42: United States Hospital Pharmacies Generic Drugs Market (in US$ Million), 2023-2030
Figure 43: United States Retail Pharmacies Generic Drugs Market (in US$ Million), 2018-2022
Figure 44: United States Retail Pharmacies Generic Drugs Market (in US$ Million), 2023-2030
Figure 45: Market Value Chain

More Publications

Need Help?

Ask a Question

Market Reports

All Categories